Compass-logo-RGB-outlines.png
Compass Therapeutics Reports 2024 Second Quarter Financial Results and Provides Corporate Update
August 12, 2024 08:00 ET | Compass Therapeutics
Compass Therapeutics announces 2nd quarter results and provides clinical results update
Compass-logo-RGB-outlines.png
Compass Therapeutics Completes Patient Enrollment in COMPANION-002, a Randomized Study of CTX-009 in Combination with Paclitaxel, and Provides an Update on the Development Plan in Biliary Tract Cancer
August 06, 2024 08:00 ET | Compass Therapeutics
Completed enrollment of the planned 150 patients in COMPANION-002, a Phase 2/3 trial of CTX-009 plus paclitaxel versus paclitaxel in patients with previously treated, unresectable advanced Metastatic...
cmi_logo.png
[Latest] Global Bispecific Antibodies Market Size/Share Worth USD 53.8 Billion by 2033 at a 24.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
April 04, 2024 12:30 ET | Custom Market Insights
Austin, TX, USA, April 04, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Bispecific Antibodies Market Size, Trends and Insights By Application (Cancer...
logo.jpg
Tobemstomig Clinical Trials Bispecific Antibodies Market Clinical Trials Drug Sales Market Forecast 2029
March 17, 2024 13:28 ET | KuicK Research
Delhi, March 17, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market Opportunity Insight 2029 Report Highlights: Global Market Forecast Till 2029: > USD 36 BillionApproved Bispecific...
logo.jpg
Plamotamab Clinical Trials Global Bispecific Antibodies Market Drug Sales Report 2029
March 17, 2024 13:23 ET | KuicK Research
Delhi, March 17, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market Opportunity Insight 2029 Report Highlights: Global Market Forecast Till 2029: > USD 36 BillionApproved Bispecific...
logo.jpg
Pidilizumab Clinical Trials Bispecific Antibodies Market Report 2029
March 17, 2024 13:09 ET | KuicK Research
Delhi, March 17, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market Opportunity Insight 2029 Report Highlights: Global Market Forecast Till 2029: > USD 36 BillionApproved Bispecific...
logo.jpg
Navicixizumab Clinical Trials Bispecific Antibodies Market Size Drug Sales Insight
March 17, 2024 13:08 ET | KuicK Research
Delhi, March 17, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market Opportunity Insight 2029 Report Highlights: Global Market Forecast Till 2029: > USD 36 BillionApproved Bispecific...
logo.jpg
Lomvastomig Clinical Trials Bispecific Antibodies Market Clinical Pipeline Insight
March 17, 2024 12:38 ET | KuicK Research
Delhi, March 17, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market Opportunity Insight 2029 Report Highlights: Global Market Forecast Till 2029: > USD 36 BillionApproved Bispecific...
logo.jpg
Imvotamab Clinical Trials Bispecific Antibodies Market Growth Outlook
March 17, 2024 12:35 ET | KuicK Research
Delhi, March 17, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market Opportunity Insight 2029 Report Highlights: Global Market Forecast Till 2029: > USD 36 BillionApproved Bispecific...
logo.jpg
Acimtamig Clinical Trial Bispecific Antibodies Market Insight 2029
March 17, 2024 12:11 ET | KuicK Research
Delhi, March 17, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market Opportunity Insight 2029 Report Highlights: Global Market Forecast Till 2029: > USD 36 BillionApproved Bispecific...